Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Rhim AD, Stanger BZ.

Prog Mol Biol Transl Sci. 2010;97:41-78. doi: 10.1016/B978-0-12-385233-5.00002-7. Review.

2.

Pancreatic cancer development and progression: remodeling the model.

Real FX, Cibrián-Uhalte E, Martinelli P.

Gastroenterology. 2008 Sep;135(3):724-8. doi: 10.1053/j.gastro.2008.07.033. Epub 2008 Aug 8. Review. No abstract available.

PMID:
18692502
3.

[Precursors to pancreatic cancer].

Søreide K, Immervoll H, Molven A.

Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):905-8. Review. Norwegian.

4.

Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?

Bernard V, Fleming J, Maitra A.

Surg Oncol Clin N Am. 2016 Apr;25(2):227-38. doi: 10.1016/j.soc.2015.11.003. Review.

PMID:
27013361
5.

Functional modules analysis based on coexpression network in pancreatic ductal adenocarcinoma.

Shi B, Wang X, Han X, Liu P, Wei W, Li Y.

Pathol Oncol Res. 2014 Apr;20(2):293-9. doi: 10.1007/s12253-013-9694-1. Epub 2013 Nov 2.

PMID:
24185439
6.

Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma.

Mazur PK, Einwächter H, Lee M, Sipos B, Nakhai H, Rad R, Zimber-Strobl U, Strobl LJ, Radtke F, Klöppel G, Schmid RM, Siveke JT.

Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13438-43. doi: 10.1073/pnas.1002423107. Epub 2010 Jul 12.

7.

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

Morris JP 4th, Wang SC, Hebrok M.

Nat Rev Cancer. 2010 Oct;10(10):683-95. doi: 10.1038/nrc2899. Epub 2010 Sep 3. Review.

8.

High Phosphorylation Status of AKT/mTOR Signal in DESI2-Reduced Pancreatic Ductal Adenocarcinoma.

Shen CC, Cui XY, He Y, Kang YH, Yi C, Yang JL, Gou LT.

Pathol Oncol Res. 2015 Apr;21(2):267-72. doi: 10.1007/s12253-014-9817-3. Epub 2014 Jul 31.

PMID:
25079376
9.

Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma.

Berchtold S, Grünwald B, Krüger A, Reithmeier A, Hähl T, Cheng T, Feuchtinger A, Born D, Erkan M, Kleeff J, Esposito I.

Cancer Lett. 2015 Jan 28;356(2 Pt B):721-32. doi: 10.1016/j.canlet.2014.10.020. Epub 2014 Oct 23.

PMID:
25449434
10.

A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.

Wang WY, Hsu CC, Wang TY, Li CR, Hou YC, Chu JM, Lee CT, Liu MS, Su JJ, Jian KY, Huang SS, Jiang SS, Shan YS, Lin PW, Shen YY, Lee MT, Chan TS, Chang CC, Chen CH, Chang IS, Lee YL, Chen LT, Tsai KK.

Gastroenterology. 2013 Nov;145(5):1110-20. doi: 10.1053/j.gastro.2013.07.040. Epub 2013 Jul 27.

PMID:
23896173
11.

Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Skoudy A, Hernández-Muñoz I, Navarro P.

J Gastrointest Cancer. 2011 Jun;42(2):76-84. doi: 10.1007/s12029-011-9258-0. Review.

PMID:
21279552
12.

Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.

Chang DZ, Ma Y, Ji B, Liu Y, Hwu P, Abbruzzese JL, Logsdon C, Wang H.

J Hematol Oncol. 2012 Apr 4;5:15. doi: 10.1186/1756-8722-5-15.

13.

Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Mihaljevic AL, Michalski CW, Friess H, Kleeff J.

Langenbecks Arch Surg. 2010 Apr;395(4):295-308. doi: 10.1007/s00423-010-0622-5. Epub 2010 Mar 18. Review.

PMID:
20237938
14.

Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma.

Hanlon L, Avila JL, Demarest RM, Troutman S, Allen M, Ratti F, Rustgi AK, Stanger BZ, Radtke F, Adsay V, Long F, Capobianco AJ, Kissil JL.

Cancer Res. 2010 Jun 1;70(11):4280-6. doi: 10.1158/0008-5472.CAN-09-4645. Epub 2010 May 18.

15.

Molecular biology of pancreatic cancer--new aspects and targets.

Schneider G, Hamacher R, Eser S, Friess H, Schmid RM, Saur D.

Anticancer Res. 2008 May-Jun;28(3A):1541-50. Review.

16.

Net expression inhibits the growth of pancreatic ductal adenocarcinoma cell PL45 in vitro and in vivo.

Li B, Wan X, Zhu Q, Li L, Zeng Y, Hu D, Qian Y, Lu L, Wang X, Meng X.

PLoS One. 2013;8(2):e57818. doi: 10.1371/journal.pone.0057818. Epub 2013 Feb 28.

17.

GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability.

Schneider G, Weber A, Zechner U, Oswald F, Friess HM, Schmid RM, Liptay S.

Int J Cancer. 2006 May 15;118(10):2405-11.

18.

Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma.

Lowy AM, Fenoglio-Preiser C, Kim OJ, Kordich J, Gomez A, Knight J, James L, Groden J.

Ann Surg Oncol. 2003 Apr;10(3):284-90.

PMID:
12679314
19.

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.

du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.

Clin Chem. 2010 Apr;56(4):603-12. doi: 10.1373/clinchem.2009.137364. Epub 2010 Jan 21.

20.

Molecular biology of pancreatic ductal adenocarcinoma.

Coleman SJ, Rhim AD.

Curr Opin Gastroenterol. 2014 Sep;30(5):506-10. doi: 10.1097/MOG.0000000000000104. Review.

PMID:
25023382

Supplemental Content

Support Center